SIRT3 and hypertrophic cardiomyopathy: In preclinical models, SIRT3 overexpression significantly mitigates cardiac hypertrophy and fibrosis, whereas SIRT3 deficiency promotes the development of hypertrophic cardiomyopathy and progressive ventricular dysfunction224,225.